Navigation Links
Manufacturers of Infant Formula Milk Asked to Do Away With Exaggerated Nutritional Claims

If you look at the promotional literature of most popular brands of infant formula milk, claims of it being an alternative to breast milk// is a definite read. These claims have been questioned by the Governments food standards agency, and have been termed ‘most misleading’ to new mothers.

To enable the correct information to new mothers and mothers-to-be, many breast milk activist groups have begun championing the cause of breast milk over formula milk. As per the recent enforcement from the Government's Food Standards Agency (FSA) and the national lead body for trading standards officers, LACORS, manufacturers of infant formula milk have been asked to do away with nutritional claims that seek to glorify formula milk; this would mean making changes in their marketing campaigns and in the packaging of formula milk.

The claims which read thus ‘closer than ever to breast milk’ and 'helps growth and the immune system' are to be done away with. This will mean that the packaging and marketing literature of popular brands like SMA, Farleys, APtamil, Cow and Gate etc will need to be altered, failing which the companies are liable to face prosecution.

Policy expert at LACORS, Les Bailey, said: 'The Department of Health has a policy to encourage breastfeeding because of its proven health benefits. It contains beneficial antibodies that are not found in infant formula. Various compositional claims, like closer to breast milk, found on packs of infant formula will no longer be allowed. They will have to go from packs and advertising. The aim is to ensure that new mothers are not unduly influenced when deciding their feeding practices. The legislation is framed in a way that it doesn't matter whether they are correct or not. It is designed to promote breastfeeding.'
AV
'"/>




Page: 1

Related medicine news :

1. Clampdown On Fake Drugs Manufacturers In India – New Bill Enacte
2. Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care
3. German Manufacturers Find a Solution for DVT
4. Infant receives first bloodless liver transplant
5. Smoking Linked To Low Infant Birth Weight
6. Banning Smoking in the Home Helps Infants
7. Benefits of Nitric Oxide in the Treatment of Premature Infants
8. New Technique to Study Infants Brain.
9. Infant Fevers Found to Reduce Allergy Risk Later In Life
10. Limiting Infants Exposure To Smoke At Home
11. fMRI Offers Insight Into An Infants Brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a ... B-595 and B-7569 vinyl label materials received certification for the ... are tested to remain intact and legible, for use on chemical drums shipped by ...
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... ... April 21, 2017 , ... Westside Dental Associates ... dental care since 1985. After thirty-two years, Dr. Latner has become one of the ... my numerous clients over the years with all their dental needs,” said Dr. Latner, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
Breaking Medicine Technology: